GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,300
+10 (0.07%)
At close: Aug 4, 2025, 3:30 PM KST

GFC Life Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2021FY 2020FY 2019FY 2018FY 20172016
Period Ending
Aug '25 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 2016
Debt / Equity Ratio
0.900.901.510.850.640.34
Upgrade
Debt / EBITDA Ratio
3.253.2513.64233.28--
Upgrade
Debt / FCF Ratio
20.7920.79----
Upgrade
Asset Turnover
0.710.710.650.600.490.46
Upgrade
Inventory Turnover
11.1811.1812.8411.698.759.38
Upgrade
Quick Ratio
0.420.420.241.461.261.43
Upgrade
Current Ratio
0.530.530.341.721.831.66
Upgrade
Return on Equity (ROE)
21.78%21.78%-28.76%4.26%-4.65%-8.67%
Upgrade
Return on Assets (ROA)
4.42%4.42%-0.02%-2.37%-5.76%-4.89%
Upgrade
Return on Capital (ROIC)
5.25%5.25%-0.03%-2.58%-6.33%-5.33%
Upgrade
Return on Capital Employed (ROCE)
12.50%12.50%----
Upgrade
Buyback Yield / Dilution
0.04%-0.01%-0.02%-100.00%50.03%-0.06%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.